You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM (""MIRTH"" AND ""SCIMITAR"" DEVICES)
SBC: TRANSMURAL SYSTEMS LLC Topic: 112NHLBI has developed the Myocardial Intramural Restraint by endovenous interstitial teTHer (MIRTH) procedure and the related Suture via Coronary sinus with Interstitial myocardial navigation for MItral and Tricuspid Annular Reduction (SCIMITAR) procedure to accomplish single- and dual-valve annuloplasty via interstitial navigation of heart muscles entered through heart veins. Clinical evaluation wi ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
AWARD LUNA LABS SBIR TOPIC #114 PHASE I- Device to Permit Continuous Self-Monitoring of Blood Oxygen Saturation During Activities of Daily Living for Individuals at Risk for Desaturation During Physical Exertion
SBC: LUNA LABS USA LLC Topic: 114The goal of this Phase I topic proposal from Luna Labs is to develop a novel wireless pulse oximeter device for at-home use that is suitable for wear during physical activity and sleep.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
COUPLED ACOUSTICAL WAVE MICROPILLAR DETECTION OF DRUGS IN BLOOD POSTMORTEM
SBC: ADVANCED SILICON GROUP, INC. Topic: 167Drug Diagnostics Including Fentanyl Strips/CODE (Cause of Death Elucidated) in Drug Overdose: Rapid and portable cause of death detection technologies to improve drug overdose-related mortality counts
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
CRISPR-Based in Vitro Diagnostic Device for Rapid Detection of Eukaryotic Pathogens
SBC: TRITON SYSTEMS, INC. Topic: 119To develop a device for the detection of drug resistant malaria.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
CRISPR-based Diagnostic for Parasites
SBC: BIOLOGICAL MIMETICS, INC. Topic: 119To develop a sensitive point-of-care diagnostic for an important neglected tropical disease, Leishmaniasis.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
CRISPR-based Tropical Infection Diagnostics
SBC: CHROMOLOGIC LLC Topic: 119To develop a device for the detection of malaria.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
SBIR PHASE I- TOPIC 123
SBC: LIFETIME OMICS, INC. Topic: 123To implement a pilot version of FAIRLYZ, a novel dataset profiling and registry solution.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
TOOLKIT FOR LEARNING AND PREDICTING ALCOHOL USE PATTERNS (SBIR PHASE II, TOPIC 019)
SBC: BIOREALM, LLC Topic: 19This contract is for a project titled, ""Toolkit for Learning and Predicting Alcohol Use Patterns (SBIR Phase II, Topic 019), and the purpose for this project is for creating a platform to accelerate alcohol research that consists of developing an innovative toolkit for learning and predicting alcohol use patterns and creating machine learning algorithms that are capable of analyzing high dimensio ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig
SBC: GLYCOSCIENTIFIC, L.L.C. Topic: 118GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in the guinea pig. Once the antibodies are produced, the Offeror will use them to evaluate the cytokines in TB infected and non-infected guinea pigs. The production of these crucial immunological reagents ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
SBC: SILVER LAKE RESEARCH CORPORATION Topic: 118Silver Lake proposes to fully characterize mAb against 6 targets produced in their three concurrent Phase 1 projects that are relevant in models of disease and inflammation, determine their usability in multiple assay types, develop user protocols for each assay type and mAb, produce quality-controlled reagents, produce multiple conjugates for each mAb, and make all reagents available for the rese ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health